Abstract

Health state utilities are commonly reported before and after disease progression following an intervention. Our objective was to describe the average health state utility values (HSUV) within stages by cancer type.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Health state utility of patients with single-level cervical degenerative disc disease: comparison of anterior cervical discectomy and fusion with cervical disc arthroplasty
Sheeraz Qureshi ... Samuel K Cho
Journal of Neurosurgery: Spine | VOL. 20
Sheeraz Qureshi, et. al.Sheeraz Qureshi ... Samuel K Cho
21 Feb 2014
Health State Utility Valuation in Patients with Triple-Class-Exposed Relapsed and Refractory Multiple Myeloma Treated with the Bcma-Directed CAR T Cell Therapy, Idecabtagene Vicleucel (ide-cel, bb2121): Results from the Karmma Trial
Michel Delforge ... Sujith Dhanasiri
Blood | VOL. 136
Michel Delforge, et. al.Michel Delforge ... Sujith Dhanasiri
05 Nov 2020
Health State Utilities for Sickle Cell Disease: A Catalog Prepared From a Systematic Review
Boshen Jiao ... Beth Devine
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 25
Boshen Jiao, et. al.Boshen Jiao ... Beth Devine
04 Sep 2021
Health state utility values by cancer stage: a systematic literature review
Mir-Masoud Pourrahmat ... Divya Pushkarna
The European journal of health economics : HEPAC : health economics in prevention and care | VOL. 22
Mir-Masoud Pourrahmat, et. al.Mir-Masoud Pourrahmat ... Divya Pushkarna
14 Jun 2021
View more papers

More From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Paper Title
Journal
Date
Author
The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value Set
-
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
--
21 Jun 2024
Market entry agreements for innovative pharmaceuticals subject to indication broadening: a case study for pembrolizumab in the Netherlands.
Renaud J S D Heine ... Carin A Uyl-De Groot
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Renaud J S D Heine, et. al.Renaud J S D Heine ... Carin A Uyl-De Groot
21 Jun 2024
MSR99 A Stacked Ensemble Approach for Building Composite Measure Models in Healthcare
P Shi ... S Zhang
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 27
P Shi, et. al.P Shi ... S Zhang
15 Jun 2024
EE98 A Theory-Based Framework to Incorporate Health Equity in Economic Assessments
S Subramanian ... S Hoover
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 27
S Subramanian, et. al.S Subramanian ... S Hoover
15 Jun 2024
View more papers